D.E. Shaw & Co’s Global Blood Therapeutics, Inc. GBT Stock Holding History

D.E. Shaw & Co’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-20,000	Closed	-$585K	–	6176
2021 Q4	$585K	Hold	20,000	–	–	﹤0.01%	4315
2021 Q3	$510K	Buy	+20,000	New	+$588K	﹤0.01%	4075
2020 Q3	–	Sell	-17,900	Closed	-$1.13M	–	4286
2020 Q2	$1.13M	Buy	+17,900	New	+$1.23M	﹤0.01%	2838
2020 Q1	–	Sell	-15,000	Closed	-$1.19M	–	4381
2019 Q4	$1.19M	Hold	15,000	–	–	﹤0.01%	2859
2019 Q3	$728K	Hold	15,000	–	–	﹤0.01%	3019
2019 Q2	$789K	Hold	15,000	–	–	﹤0.01%	2819
2019 Q1	$794K	Hold	15,000	–	–	﹤0.01%	2734
2018 Q4	$616K	Buy	+15,000	New	+$562K	﹤0.01%	2973

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

D.E. Shaw & Co's GBT Position: Q4 2022 in Review

D.E. Shaw & Co sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 279,400 shares — an estimated $19M sold.

D.E. Shaw & Co first reported a position in GBT in Q1 2016 and held it in 20 quarters. The position peaked at $19M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

D.E. Shaw & Co reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
D.E. Shaw & Co sold 279,400 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $19M.
D.E. Shaw & Co first reported a position in Global Blood Therapeutics, Inc. in Q1 2016 and held it in 20 quarters.
D.E. Shaw & Co's Global Blood Therapeutics, Inc. position peaked at $19M in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.